Darolutamide + ADT for Metastatic Hormone-Sensitive Prostate Cancer: ARASEC
This Medudy course is a video tutorial for physicians on the topic of “Darolutamide + ADT for Metastatic Hormone-Sensitive Prostate Cancer (ARASEC).” The format used here is a “Journal Club Summary,” in which we summarize the latest and most clinically relevant studies for you. In metastatic hormone-sensitive prostate cancer (mHSPC), the combination of an androgen receptor pathway inhibitor (ARPI) […]
Olaparib: Developments and Prospects for PARP Inhibition in Cancer Therapy
This Medudy series is a video tutorial for physicians on “Olaparib: Developments and Prospects for PARP Inhibition in Cancer Therapy.” This four-part module examines the use of olaparib in various oncological indications and is presented by an interdisciplinary team of experts. To begin, Professor Peter Hammerer discusses combination therapy with olaparib and abiraterone […]
Treatment of Metastatic Cervical Cancer
This Medudy course is a video tutorial for physicians on the topic “Treatment of Metastatic Cervical Cancer: Tisotumab Vedotin and the KEYNOTE-826 Trial.” The format used here is a “Journal Club Summary,” in which we summarize the latest and most clinically relevant studies for you. For patients with recurrent or metastatic cervical cancer, treatment options after […]
Treatment of Locally Advanced Cervical Cancer (KEYNOTE-A18 Trial)
This Medudy course is a video tutorial for physicians on the topic “KEYNOTE-A18: Pembrolizumab Plus Radiochemotherapy for Locally Advanced Cervical Cancer.” The format used here is a “Journal Club Summary,” in which we summarize the latest and most clinically relevant studies for you. Patients with locally advanced cervical cancer continue to have a significant […] despite combined chemoradiotherapy.
mCRPC – metastatic castration-resistant prostate cancer
This Medudy Master Class Series is a video tutorial for physicians on prostate cancer. This four-part module focuses on metastatic castration-resistant prostate cancer (mCRPC) and is presented by Prof. Dr. Martin Bögemann, senior physician in urology and pediatric urology at the University Hospital in Münster. The first part deals with first-line therapy for mCRPC, taking into account the […]
AVANT GUARD: Pulsed-field ablation as a first-line treatment for persistent atrial fibrillation
This Medudy course is a video tutorial for physicians on the topic of “Pulsed-field ablation as first-line therapy for persistent atrial fibrillation.” The format used here is a “Journal Club Summary,” in which we summarize the latest and most clinically relevant studies for you. For paroxysmal atrial fibrillation, catheter ablation is already recognized as a first-line therapy; for persistent atrial fibrillation, […]
The Capla 1000+ Project
This Medudy course is a video tutorial for physicians on the topic of “The Capla 1000+ Project.” The format used here is a “Journal Club Summary,” in which we summarize individual studies for you. Caplacizumab is a monoclonal nanobody that inhibits the binding of platelets to von Willebrand factor and has been approved since 2018 for the treatment of […]
HER2 Diagnostics as the Key to Targeted Therapy Decisions
This Medudy course is a video tutorial for physicians on the topic “HER2 Diagnostics as the Key to Targeted Therapy Decisions.” In this video, Professor Markus Eckstein, senior physician at the Institute of Pathology at Erlangen University Hospital, explains the relationship between HER2 diagnostics and the use of targeted therapies for various solid tumors. Essentially, there are three therapeutically relevant alterations […]
63rd ERA Congress 2026 – Key Highlights
This Medudy course is a conference report for physicians on the topic “63rd ERA Congress 2026 – Key Highlights.” Prof. Dr. Jörg Latus, Head of the Department of Internal Medicine and Nephrology at Robert Bosch Hospital in Stuttgart, will summarize key study highlights from the conference for you. The results of the Phase III FIND-CKD study evaluating the efficacy and […] will be presented.
ASCO 2026 – Updates on RCC & MIBC
This Medudy course is a conference report for physicians on the topic “ASCO 2026 – Updates on RCC & MIBC.” Prof. Dr. med. Günter Niegisch, senior physician at the Department of Urology at the University Hospital of Düsseldorf, will summarize key study highlights from the conference for you. The presentation will cover the results of a study on patients’ perception of toxicity following adjuvant ICI therapy and […]